Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA235747,10.1007/s10555-023-10109-y,Cancer Metastasis Rev,37286865,https://pubmed.ncbi.nlm.nih.gov/37286865,Epigenetic markers and therapeutic targets for metastasis,2023,"Plasticity, Metastasis, Circulating Tumor Cells, Epigenetic Biomarkers, Epi-drugs","Carolyn J Kravitz, Qin Yan, Don X Nguyen","The last few years have seen an increasing number of discoveries which collectively demonstrate that histone and DNA modifying enzyme modulate different stages of metastasis. Moreover, epigenomic alterations can now be measured at multiple scales of analysis and are detectable in human tumors or liquid biopsies. Malignant cell clones with a proclivity for relapse in certain organs may arise in the(Read more on Pubmed)",Targeted Therapy Agent,Pan-cancer,Not Applicable,Not Appicable,Open Access,37286865,a156f7dc-af99-4edd-b0be-cab2d6bb2f58,syn52565380
